Biosimilar Newsletter Archive

  1. 08.15.24 -- Your Molecule May Be Ready, But What About Your Device? 8/15/2024

    08/15/24 Biosimilar Development Newsletter

  2. 08.15.24 -- Harnessing Analytics To Minimize Antibody Variants 8/15/2024
    08/15/24 Biosimilar Development Newsletter
  3. 08.08.24 -- The Biosimilars Forum Supports House Committee Probe Into The PBM Monopoly 8/8/2024
    08/08/24 Biosimilar Development Newsletter
  4. 08.05.24 -- Explore The Benefits Of Outsourcing To A Polish CDMO 8/5/2024

    08/05/24 Biosimilar Development Newsletter

  5. 08.01.24 -- Sandoz Launches Biosimilar Pyzchiva Across Europe 8/1/2024
    08/01/24 Biosimilar Development Newsletter
  6. 07.25.24 -- Life Cycle Planning For Drug Product Containment And Delivery 7/25/2024

    07/25/24 Biosimilar Development Newsletter

  7. 07.25.24 -- Using The ADKAR Model In Biopharma Change Management 7/25/2024
    07/25/24 Biosimilar Development Newsletter
  8. 07.18.24 -- Maximize Bioprocessing Uptime With Comprehensive Service Solutions 7/18/2024

    07/18/24 Biosimilar Development Newsletter

  9. 07.18.24 -- SFMEA: An Alternative Approach For Analyzing Risks 7/18/2024
    07/18/24 Biosimilar Development Newsletter
  10. 07.11.24 -- Where's The Case For Generative AI In Biopharma Manufacturing? 7/11/2024
    07/11/24 Biosimilar Development Newsletter